А. В. Амелин

ORCID: 0000-0001-6437-232X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Migraine and Headache Studies
  • Agriculture and Biological Studies
  • Agricultural Productivity and Crop Improvement
  • Neurological Disorders and Treatments
  • Seed and Plant Biochemistry
  • Trigeminal Neuralgia and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Magnetic and Electromagnetic Effects
  • Agriculture, Plant Science, Crop Management
  • Agricultural Development and Policies
  • Olfactory and Sensory Function Studies
  • Neuroscience of respiration and sleep
  • Medical and Biological Sciences
  • Parkinson's Disease Mechanisms and Treatments
  • Peripheral Neuropathies and Disorders
  • Botulinum Toxin and Related Neurological Disorders
  • Wheat and Barley Genetics and Pathology
  • Food Industry and Aquatic Biology
  • Biochemical effects in animals
  • Neurological disorders and treatments
  • Fusion and Plasma Physics Studies
  • Soil and Environmental Studies
  • Human Health and Disease
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Parathyroid Disorders and Treatments

First Pavlov State Medical University of St. Petersburg
2016-2025

Orel State Agrarian University
2016-2023

ITMO University
2016-2017

EVRAZ (Canada)
2014

Institute of Pharmacology
2011

Alberto J. Espay Fabrizio Stocchi Rajesh Pahwa Alberto Albanese Aaron Ellenbogen and 84 more Joaquim J. Ferreira Nir Giladi Tanya Gurevich Sharon Hassin‐Baer Jorge Hernández‐Vara Stuart Isaacson Karl Kieburtz Peter A. LeWitt Lydia López Manzanares C. Warren Olanow Werner Poewe Harini Sarva Tami Yardeni Liat Adar Laurence Salin Nelson Lopes Noah J. Sasson Ryan Case Olivier Rascol Mitra Afshari А. В. Амелин David Arkadir Samih Badarny Ernest Balaguer Martinez Andrzej Bogucki James T. Boyd Laura Buyan Dent Camille Carroll К. Ray Chaudhuri Jeffrey W. Cooney Anne-Gaëlle Corbillé Téodor Danaila Maria Francesca De Pandis Sophie Dethy Rohit Dhall Ruth Djaldetti Franck Durif Stephen Flitman Eric Freire Alvarez John L. Goudreau Francisco Grandas Perez Tanya Gurevich Arnaldo Isa Jorge L. Juncos Sulada Kanchana Gabriela Kłodowska-Duda Dariusz Koziorowski J. Kulisevsky Bojarski Juan Lopez Lozano Lan Luo N. V. Lytvynenko Roberto Marconi Ana Marqués Juan Carlos Martínez‐Castrillo Irene Martínez‐Torres Aashoo Mentreddi Pablo Mir Rivera Sergii Moskovko Y. N. Neryanova Marco Onofrj Jill L. Ostrem Claudio Pacchetti Nicola Pavese Clelia Pellicano Gonzalo J. Revuelta Margarida Rodrigues Ramon L. Rodriguez Monika Rudzińska Nighat Sarwar Julie Schwartzbard Laura Scorr John T. Slevin Tatyana Slobodin Gianfranco Spalletta Michele Tagliati Yen Tai Alessandro Tessitore Peter Valkovič Leo Verhagen Е. А. Вострикова Gilad Yahalom Zuleykha Zalyalova Kateřina Zárubová Irina Zhukova

10.1016/s1474-4422(24)00052-8 article EN The Lancet Neurology 2024-03-15

Foslevodopa/foscarbidopa, a soluble formulation of levodopa/carbidopa (LD/CD) prodrugs for the treatment Parkinson's disease (PD), is administered as 24-hour/day continuous subcutaneous infusion (CSCI) with single site. The efficacy and safety foslevodopa/foscarbidopa versus oral immediate-release LD/CD was previously demonstrated in patients PD 12-week, randomized, double-blind, phase 3 trial (NCT04380142). We report results separate 52-week, open-label, registrational (NCT03781167) that...

10.1007/s40120-023-00533-1 article EN cc-by-nc Neurology and Therapy 2023-08-26

The Russian experts’ guidelines on evaluation and treatment of medication-overuse headache are based evidence-based medicine, the latest revision International Classification Headache Disorders. Basic information about epidemiology, risk factors, pathophysiological mechanisms, evaluation, most effective pharmacological drug non-pharmacological approaches to managing patients with presented.

10.14412/2074-2711-2022-1-4-13 article EN cc-by Neurology neuropsychiatry Psychosomatics 2022-02-22

Migraine is one of the most common types headache, which can lead to a significant decrease in quality life. Researchers identify migraine with aura, without and chronic that substantially reduces ability patients work frequently concurrent mental disorders drug-induced headache. The complications include status migrainosus, persistent aura infarction, migrainous infarction (stroke), aura-induced seizure. diagnosis based on complaints, past medical history, objective examination data,...

10.14412/2074-2711-2020-4-4-14 article EN cc-by Neurology neuropsychiatry Psychosomatics 2020-08-27

Migraine is a chronic neurological disorder that associated with considerable disadaptive effect on patients. Despite the development of pharmacotherapy strategies for migraine, only one third patients are satisfied their overall treatment. Many migraine turn to complementary and alternative medicine (CAM), which not usually considered part conventional always evidence-based. In practise, however, they often used improve effectiveness standard therapy or provide addition, in CAM methods,...

10.14412/2074-2711-2024-1-4-15 article EN cc-by Neurology neuropsychiatry Psychosomatics 2024-02-16

Chronic imflammatory demyelinating polyneuropathy (CIPD) is a heterogenous group of disimmune polyneuropathies, characterised by progressive or relapsing-remitting disease course, with electrophysiologically and pathomorphologically detected peripheral nerve demyelination. Immunotherapy considered reasonable in CIDP. CIDP associated antibodies against nodo-paranodal proteins, namely, NF155, CNTN1, Contactin protein has been described amongst the rare atypical subtypes. The detection proteins...

10.33667/2078-5631-2024-33-13-18 article EN Medical alphabet 2025-01-24

Objective. To present the recommendations of expert council Russian Society for Study Pain on “Dorsumio” drug in treatment chronic nonspecific back pain (CNBP). Key points. Currently, CNBP is leading disease associated with disability worldwide. Patients often experience concomitant depressive and anxiety symptoms complicating course therapy, as well worsening quality life working capacity. Various problems care include not only impact pathogenesis pain, but also depression, anxiety,...

10.17116/pain20252301192 article EN Russian Journal of Pain 2025-03-13

On November 08, 2024 in Moscow, under the auspices of Russian Society for Study Pain (RSSP), a Council Experts was held, during which leading specialists field neurology, who have high level expertise treatment back pain, discussed modern approaches to therapy discogenic lumbosacral radiculopathy (DLSR). The actualized pathogenetic mechanisms disease onset and progression; pathogenesis, are currently still insufficiently affected by pharmacotherapeutic intervention. Conservative DLSR is...

10.17116/pain20252301184 article EN Russian Journal of Pain 2025-03-13

On December 24, 2022, in Moscow an interdisciplinary Council of Headache Experts, held under the auspice interregional public organization “Russian Society for Study Headache”, discussed key problems effective treatment a migraine attack and possibilities specific drug Kaporiza® (rizatriptan). Despite development strategies relief attacks effectiveness triptans as first-line therapy, choice accordance with individual clinical profile patient is difficult due to existence drugs various forms...

10.14412/2074-2711-2023-2-126-133 article EN cc-by Neurology neuropsychiatry Psychosomatics 2023-05-01

The autonomous cardiovascular control can contribute to progression of migraine. However, current data on reactivity in migraine, especially severe forms, are essentially contradictory. main aim this study was compare the regulation circulation patients with episodic and chronic migraine healthy subjects. Seventy three (mean age 35 ± 10) including (51 patients, 4–14 headache days/months) (22 ≥15 days/month) along age-match (71 voluntaries) were examined. autonomic examined tilt-table test, a...

10.1186/s10194-016-0645-6 article EN cc-by The Journal of Headache and Pain 2016-05-11

These recommendations on the diagnosis and treatment of migraine were elaborated by Russian headache experts in accordance with evidence-based practice. Together latest classification, diagnostic principles criteria different clinical sub-forms consensus contains basic data epidemiology, pathophysiological mechanisms, differential most effective evidence based approaches to pharmacological non-pharmacological management patients.Представленные рекомендации по диагностике и лечению мигрени...

10.17116/jnevro20171171228-42 article RU S S Korsakov Journal of Neurology and Psychiatry 2017-01-01

This consensus reviewed the main current issues of clinical application and integration into everyday practice a new targeted preventive therapy for migraine using monoclonal antibodies (mAbs) to calcitonin gene related peptide (CGRP) ligand or receptor. These recommendations are based on scientific studies an analysis results several years use. The purpose is assist practitioners in prescribing effective prophylactic treatment anti-CGRP mAbs improve care patients with various forms disease.

10.14412/2074-2711-2022-5-109-116 article EN cc-by Neurology neuropsychiatry Psychosomatics 2022-10-25

The non-invasive biomarkers of migraine can help to develop the personalized medication this disorder. In testing antimigraine drugs capsaicin-induced skin redness with activated TRPV1 receptors in sensory neurons associated release mediator CGRP has already been widely used.Fourteen patients (mean age 34.6 ± 10.2 years) and 14 healthy volunteers 29.9 9.7 participated experiment. A new arrangement imaging photoplethysmography recently developed by us was used here discover novel sensitive...

10.1186/s10194-018-0872-0 article EN cc-by The Journal of Headache and Pain 2018-06-18

Depression is one of the most common medical causes disability and mortality in patients all ages. Depressive disorders are practice physicians a variety specialties, including psychiatrists, neurologists, physicians. This paper provides summary review literature on modern ideas about epidemiology, classification, clinical picture depression. Current approaches to diagnosis treatment depressive neurological psychiatric discussed. Modern pharmacotherapeutic strategies for depression various...

10.14412/2074-2711-2023-5-54-64 article EN cc-by Neurology neuropsychiatry Psychosomatics 2023-10-23

The resolution of the expert council is devoted to discussing aspects use ipidacrine for treatment mononeuropathies, polyneuropathies and radiculopathies various etiologies. Specialists prepared recommendations ipidacrine's application in treating peripheral nervous system disorders.

10.17116/jnevro2024124021158 article EN S S Korsakov Journal of Neurology and Psychiatry 2024-01-01

Migraine is the second leading cause of maladjustment, and burden migraine determined by its impact on work ability, social activity family relationships. Objective: to identify patterns behavior Russian patients with migraine, factors affecting their quality life, level awareness disease based a semantic analysis messages in Web 2.0. Patients methods. The study results processing (automated natural language texts, taking into account meaning) anonymized from 6566 unique authors (patients...

10.14412/2074-2711-2021-6-73-84 article EN cc-by Neurology neuropsychiatry Psychosomatics 2021-12-15

Представлен обзор сведений литературы и клиническое наблюдение с не Val30Met-транстиретиновой амилоидной кардиомиопатией. Обсуждены алгоритмы диагностики врачебной тактике на современном этапе.

10.15829/1560-4071-2018-2-121-128 article RU cc-by Russian Journal of Cardiology 2018-03-09

Relevance. The absence of a registered vaccine against G145R escape mutant determines the need to develop drug for prophylaxis infectious hepatitis caused by B virus. aim study was evaluate safety and reactogenicity new recombinant Bubo®-Unigep yeast in healthy volunteers. Materials & Methods. To confirm trivalent vaccine, an open, single- center, nonrandomized clinical trial conducted male volunteers at base «Uromed» (Smolensk) according protocol developed contract research organization...

10.31631/2073-3046-2019-18-6-45-52 article EN cc-by Epidemiology and Vaccinal Prevention 2020-01-16

10.26442/2075-1753_2016.9.103-109 article EN Consilium Medicum 2016-01-01
Coming Soon ...